Another good year for JYC, another business that has the red flag of fiddling with financials though. NPAT and therefore EPS dropped slightly from PRP, but headline reporting in the 4E is for "normalised" earnings which show a rise in NPAT. Will be interesting to see Mr Market's reaction, my guess is most people just see the reported rise in earnings.
The good news is that the cash conversion has been very strong with FCF running ahead of NPAT significantly, this is increased further by the sale of investment properties which in turn has fuelled a big jump in dividend.
Outlook is cautious with a soft start to FY 2024.